Ingredients Overview
Cinnamon (Bark) - Used as a medicine for several thousand years in both Eastern and Western traditions to relieve blood pressure, improve insulin sensitivity, decrease glucose intolerance and reduce blood glucose levels. An active principle, Cinnamaldehyde (CND), found in cinnamon, has been identified as an active principle against diabetes. Studies have shown that cinnamon, when used as dietary supplement can effectively regulate blood glucose and blood pressure levels along with conventional medications to treat type 2 diabetes. In addition, diet contains cinnamon compounds could reduce risk factors associated with diabetes and cardiovascular disease. However, the glycaemic control and insulin sensitivity effect can be quickly reversed if used alone.
Suhash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde--a potential antidiabetic agent. Phytomedicine. 2007 Jan;14(1):15-22. Epub 2006 Nov 30.
Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med. 2010 Oct;27(10):1159-67.
Anand P, Murali KY, Tandon V, Murthy PS, Chandra R, Dr. B.R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate, carboxykinase, and GLUT4 translocation in experimental diabetic rats.
Chem Biol Interact. 2010 Jun 7;186(1):72-81. Epub 2010 Apr 2.
Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med. 2010 Mar;76(5):412-7. Epub 2009 Oct 29.
Roussel AM, Hininger I, Benaraba R, Ziegenfuss TN, Anderson RA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr. 2009 Feb;28(1):16-21.
Ziegenfuss TN, Hofheins JE, Mendel RW, Landis J, Anderson RA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr. 2006 Dec 28:3:45-53.
Jitomir J, Willoughby DS. Cassia cinnamon for the attenuation of glucose intolerance and insulin resistance resulting from sleep loss. J Med Food. 2009 Jun;12(3):467-72.
Anderson RA. Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc. 2008 Feb;67(1):48-53.
Solomon TP, Blannin AK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol. 2009 Apr;105(6):969-76. Epub 2009 Jan 22.
Kim SH, Choung SY. Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon Bark) extract in mice. Arch Pharm Res. 2010 Feb;33(2):325-33. Epub 2010 Feb 24.
Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003 Dec;26(12):3215-18.
Fenugreek (seed) - Fenugreek seeds have a long history in folk medicine to reduce blood sugar. Adding fenugreek into acceptable baked products has shown to reduce insulin resistance in type 2 diabetes. Studies showed it exhibits insulinotropic and anti-obesity effects for insulin-independent diabetes. In addition, it may be useful for the management of glucose metabolic disorder.
Kassaian, N., et al. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Infectious Diseases Research Center. 2009 Jan;79(1):34-9.
Ogawa J, Kodera T, Smirnov SV, Hibi M, Samsonova NN, Koyama R, Yamanaka H, Mano J, Kawashima T, Yokozeki K, Shimizu S. A novel L: -isoleucine metabolism in Bacillus thuringiensis generating (2S, 3R, 4S)-4-hydroxyisoleucine, a potential insulinotropic and anti-obesity amino acid. Appl Microbiol Biotechnol. 2010 Nov 11.
Moorthy R, Prabhu KM, Murthy PS. Anti-hyperglycemic compound (GII) from fenugreek sees, its purification and effect in diabetes mellitus. Indian J Exp Biol. 2010 Nov;48(11):1111-8.
Uemura T, Goto T, Kang MS, Mizoguchi N, Hirai S, Lee JY, Nakano Y, Shono J, Hoshino S, Taketani K, Tsuge N, Narukami T, Makishima M, Takahashi N, Kawada T. Diosgenin, the main aglycon of fenugreek, Inhibits LXR{alpha} activity in HepG2 cells and decreases plasma and hepatic triglycerides in obese diabetic mice. J Nutr. 2010 Nov 24.
Uemura T, Hirai S, Mizoguchi N, Goto T, Lee JY, Taketani K, Nakano Y, Shono J, Hoshino S, Tsuge N, Narukami T, Takahashi N, Kawada T. Diosgenin present in fenugreek improves glucose metabolism by promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol Nutr Food Res. 2010 Nov;54(11):1596-608.
Losso JN, Holliday DL, Finley JW, Martin RJ, Rood JC, Yu Y, Greenway FL. Fenugreek bread: a treatment for diabetes mellitus. J Med Food. 2009 Oct;12(5):1046-9.
Hamden K, Masmoudi H, Carreau S, Elfeki A. Immunomodulatory, beta-cell, and neuroprotective actions of fenugreek oil fromalloxan-induced diabetes. Immunopharmacol Immunotoxicol. 2010 Sep;32(3):437-45.
Kassaian N, Azadbakht L, Forghani B, Amini M. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2 diabetic patients. Int J Vitam Nutr Res. 2009 Jan;79(1):34-9.
Haeri MR, Izaddoost M, Ardekani MR, Nobar MR, White KN. The effect of fenugreek 4-hydroxyisoleucine on liver function biomarkers and glucose in diabetic and fructose-fed rats. Phytother Res. 2009 Jan;23(1):61-4.
Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of trigonella foenum-graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007;16 Suppl 1:422-6.
Hannan JM, Ali L, Rokeya B, Khaleque J, Akhter M, Flatt PR, Abdel-Wahab YH. Soluble dietary fibre fraction of trigonella foenum-graecum (fenugreek) seed improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption, and enhancing insulin action. Br J Nutr. 2007 Mar;97(3):514-21.
Kumar GS, Shetty AK, Salimath PV, Modulatory effect of fenugreek seed mucilage and spent turmeric on intestinal and renal disaccharidases in streptozotocin induced diabetic rats. Plant Foods Hum Nutr. 2005 Jun;60(2):87-91.
Vijayakumar MV, Singh S, Chhipa RR, Bhat MK. The hypoglycaemic activity of fenugreek seed extract is mediated through the stimulation of an insulin signaling pathway. Br J Pharmacol. 2005 Sep;146(!):41-8.
Thakran S, Siddiqui MR, Baquer NZ. Trigonella foenum graecum seed powder protects against histopathological abnormalities in tissues of diabetic rats. Mol Cell Biochem. 2004 Nov;266(1-2):151-9.
Flammang AM, Cifone, MA, Erexson GL, Stankowski LF Jr. Genotoxicity testing of a fenugreek extract. Food Chem Toxicol. 2004 Nov;42(11):1769-75.
Mondal DK, Yousuf BM, Banu LA, Ferdousi R, Khalil M, Shamim KM. Effect of fenugreek seeds on the fasting blood glucose level in the streptozotocin induced diabetic rats. Mymensingh Med J. 2004 Jul;13(2):161-4.
Ginger (root) - On the FDA's "Generally Recognized As Safe (GRAS)" list, ginger has been described in traditional Chinese medicine and Ayurveda for thousands of years for treating different inflammatory diseases. One of the component found in ginger, curcumin, is now being used to treat cancer, arthritis, diabetes, Crohn's disease, cardiovascular diseases, osteoporosis, Alzheimer's disease, psoriasis, and other pathologies. Another major component found in ginger roots, zingerone, exhibits preventive measure against chronic inflammatory conditions that underlie many age-related inflammatory diseases, such as metabolic syndrome, cardiovascular disease, dementia, arthritis, diabetes, osteoporosis, and caners. Studies have shown ginger could enhances insulin sensitivity, decrease blood cholesterol & triglyceride and lower blood pressure in diabetic rats.<
Sekiya K, et al. Enhancement of insulin sensitivity in adipocytes by ginger. Biofactors. 2004;22(1-4):153-6.
Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann NY Acad Sci. 2005 Nov;1056:206-17.
Akhani SP, Vishwakarma SL, Goyal RK. Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. J Pharm Pharmacol. 2004 Jan; 56(1):101-5.
Kim MK, Chung SW, Kim DH, Kim JM, Lee EK, Kim JY, Ha YM, Kim YH, No JK, Chung HS, Park KY, Rhee SH, Choi JS, Yu BP, Yokozawa T, Kim YJ, Chung HY. Modulation of age-related NF-kappaB activation by dietary zingerone via MAPK pathway. Exp Gerontol. 2010 Jun;45(6):419-26. Epub 2010 Mar 6.
Goldthread Rhizome (Root) - Used for more than 1400 years in China to treat diabetes, goldthread rhizome is considered as one of the 50 fundamental herbs in traditional Chinese medicine. In recent year, it was reported to have beneficial effects on the metabolism disorders states of diabetes, including regulating the blood cholesterol & triglyceride, lowering blood glucose, decreasing insulin resistance, and influencing the function of the pancreatic beta cell. Berberine is one of the main constituents of goldthread rhizome (or sometimes called coptidis rhizome) that has shown to ameliorate renal dysfunction in diabetic nephropathy rats. More than 2000 published papers studying the clinical application, pharmacodynamic mechanism and structure-activity relationship of berberine and its derivatives for treating tumor, diabetes, Alzheimer's disease, osteoporosis, etc. Goldthread rhizome has beneficial uses in the development of therapeutic and preventive agents for diabetic complications and diabetes mellitus.
Jung HA, Yoon NY, Bae HJ, Min BS, Choi JS. Inhibitory activities of the alkaloids from coptidis rhizoma against aldose reductase. Arch Pharma Res. 2008 Nov;31(11):1405-12. [PMID: 19023536]
Liu WH, Hei ZQ, Nie H, Tang FT, Huang HQ, Li XJ, Deng YH, Chen SR, Guo FF, Huang WG, Chen FY, Liu PQ. Berberine ameliorates renal injury in streptozotocin-induced diabetic rats by suppression of both oxidative stress and aldose reductase. Chin Med J (Engl). 2008 Apr 20;121(8):706-12.
Liu W, Tang F, Deng Y, Li X, Lan T, Zhang X, Huang H, Liu P. Berberine reduces fibronectin and collagen accumulation in rat glomecular mesangial cells cultured under high glucose condition. Mol Cell Biochem. 2009 May;325(1-2):99-105. Epub 2009 Jan 14.
Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol. 2006 Nov 3;108(1):109-15. Epub 2006 May 2.
Kwon KB, Kim EK, Lim JG, Shin BC, Han SC, Song BK, Kim KS, Seo EA, Ryu DG. Protective effect of Coptidis Rhizoma on S-nitroso-N-acetylpenicillamine (SNAP)-induced apoptosis and necrosis in pancreatic RINm5F cells. Life Sci. 2005 Jan 7;76(8):917-29.
Shen N, Li CN, Huan Y, Shen ZF. Advances of the mechanism study on berberine in the control of blood glucose and lipid as well as metabolism disorders. Yao Xue Xue Bao. 2010 Jun;45(6):699-704.
Li B, Zhu WL, Chen KX. Advances in the study of berberine and its derivatives. Yao Xue Xue Bao. 2008 Aug;43(8):773-87.
Licorice (root) - A study by Hence Choi et al (2008) showed that roasted licorice ethanol extracts may be a beneficial agent that results in blunting diabetes-associated endothelial dysfunction and vascular complications.
Choi, YJ., et al. Blockade of nitroxidate stress by roasted licorice extracts in high glucose-exposed endothelial cells. J Cardiovasc Pharmacol. 2008 Oct;52(4):344-54.
Mulberry (leaf) - Researchers all over the world are exploring herbal supplements to control diabetes and its complications. Mulberry leaves have long been used in traditional Chinese medicine for the prevention and treatment of diabetes. In Thailand, beverages containing mulberry leaf are believed to promote good health, especially in people with diabetes. Demonstrated by many studies, mulberry leaf has been suggested to exhibits potential characteristics of regulating fasting and postprandial blood glucose, decreasing serum triglycerides, phospholipids, and cholesterol when used in therapy or used as dietary supplement. One study even showed the mulberry leaves were more effective than the oral hypoglycemic drug - glibenclamide.
Kimura, T., et al. Food-grade mulberry powdeer enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem. 2007 Jul;55(11):5869-74.
Sharma SB, Gupta S, Ac R, Singh UR, Rajpoot R, Shukla SK. Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin-induced diabetic rats. J Pharm Pharmacol. 2010 Feb;62(2):247-55.
Andallu B, Vinay Kumar AV, Varadacharyulu NCh. Lipid abnormalities in streptozotocin-diabetes: Amelioration by Morus indica L. cv Suguna leaves. Int J Diabetes Dev Ctries. 2009 Jul;29(3):123-8.
Naowaboot J, Pannangpetch P, Kukongviriyapan V, Kukongviriyapan U, Nakmareong S, Itharat A. Mulberry leaf extract restores arterial pressure in streptozotocin-induced chronic diabetic rats. Nutr Res. 2009 Aug;29(8):602-8.
Naowaboot J, Pannanpgetch P, Kukongviriyapan V, Kongyingyoes B, Kukongviriyapan U, Antihyperglycemic, antioxidant and antiglycation activities of mulberry leaf extract in streptozotocin-induced chronic diabetic rats. Plant Foods Hum Nutr. 2009 Jun;64(2):116-21.
Sugimoto M, Arai H, Tamura Y, Murayama T, Khaengkhan P, Nishio T, Ono K, Ariyasu H, Akamizu T, Ueda Y, Kita T, Harada S, Kamei K, Yokode M. Mulberry leaf ameliorates the expression profile of adipocytokines by inhibiting oxidative stress in white adipose tissue in db/db mice. Atherosclerosis. 2009 Jun;204(2):388-94. Epub 2008 Oct 30.
Kimura T, Nakagawa K, Kubota H, Kojima Y, Goto Y, Yamagishi K, Oita S, Oikawa S, Miyazawa T, Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J Agric Food Chem. 2007 Jul 11;55(14):5869-74. Epub 2007 Jun 8.
Andallu B, Varadacharyulu NC. Gluconeogenic substrates and hepatic gluconeogenic enzymes in streptozotocin-diabetic rats: effect of mulberry (Morus indica L.) leaves. J Med Food. 2007 Mar;10(1):41-8.
Oku T, Yamada M, Nakamura M, Sadamori N, Nakamura S, Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br J Nutr. 2006 May;95(5):933-8.
Oat (fiber) - Generally considered "healthy" or a health food, oat and oat by-products have been proven to be helpful in the treatment of diabetes and cardiovascular disorders. Many studies showed that diets that are high in beta-glucan (a component of oats) can help with the postprandial rise in blood glucose levels and reduce the risk of type 2 diabetes and cardiovascular disease.
Liatis, S., et al (2009). The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab. Apr;35(2):115-20.
Sadiq Butt M, Tahir-Nadeem M, Khan MK, Shabir R, Butt MS. Oat: unique among the cereals. Eur J Nutr. 2008 Mar;47(2):68-79. Epub 2008 Feb 26.
Panahi S, Ezatagha A, Temelli F, Vasanthan T, Vuksan V. Beta-glucan from two sources of oat concentrates affect postprandial glycemia in relation to the level of viscosity. J Am Coll Nutr. 2007 Dec;26(6):639-44.
Weickert MO, Mohlig M, Schofl C, Arafat AM, Otto B, Viehoff H, Koebnick C, Kohl A, Spranger J, Pfeiffer AF. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006 Apr;29(4):775-80.
Tapola N, Karvonen H, Niskanen L, Mikola M, Sarkkinen E. Oy Glycemic responses of oat bran products in type 2 diabetic patients. Nutr Metab Cardiovasc Dis. 2005 Aug;15(4):255-61.
Wursch P, Pi-Sunyer FX. The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in beta-glucan. Diabetes Care. 1997 Nov;20(11):1774-80.
Pick ME, Hawrysh ZJ, Gee MI, Toth E, Garg ML, Hardin RT. Oat bran concentrate bread products improve long-term control of diabetes: a pilot study. J Am Diet Assoc. 1996 Dec;96(12):1254-61.
Braaten JT, Scott FW, Wood PJ, Riedel KD, Wolynetz MS, Brule D, Collins MW. High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet Med. 1994 Apr;11(3):312-8.
Psyllium (seed) - Used in the US, Europe, China, and India for a long time, psyllium, has been suggested by many recent studies to exhibit the potential to help decreasing blood glucose, glycosylated hemoglobin (HbA1c), and triglycerides in diabetic patients.
Ziai SA., et al. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. Journal of Ethnopharmacology. 2005 Nov;102(2):202-207.
Moreno LA, Tresaco B, Bueno G, Fleta J, Rodriguez G, Garagorri JM, Bueno M. Psyllium fibre and the metabolic control of obese children and adolescents. J Physiol Biochem. 2003 Sep;59(3):235-42.
Sartore G, Reitano R, Barison A, Magnanini P, Cosma C, Burlina S, Manzato E, Fedele D, Lapolla A. The effects of psyllium on lipoproteins in the type II diabetic patients. Eur J Clin Nutr. 2009 Oct;63(10):1269-71. Epub 2009 Jul 22.
Petchetti L, Frishman WH, Petrillo R, Raju K. Nutriceuticals in cardiovascular disease: psyllium. Cardiol Rev. 2007 May-Jun;15(3):116-22.
Singh B. Psyllium as therapeutic and drug delivery agent. Int J Pharm. 2007 Apr 4;334(1-2):1-14. Epub 2007 Jan 21.
Ziai SA, Larijani B, Akhoondzadeh S, Fakhrzadeh H, Dastpak A, Bandarian F, Resai A, Badi HN, Emami T. Psyllium decreased serum glucose and glycosylated hemoglobin significantly in diabetic outpatients. J Ethnopharmacol. 2005 Nov 14;102(2):202-7. Epub 2005 Sep 8.
Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP. Therapeutic effects of psyllium in type 2 diabetic patients. Eur J Clin Nutr. 2002 Sep;56(9):830-42.
Radix Ginseng (root) - Well known medicinal plant used in traditional Chinese medicine, ginseng, has made a successful transition from the world of traditional tonic remedies to conventional medicine. Since the 1920s, ginseng root has been documented in many studies to be effective in diabetes, hypertension, dyslipidemia and obesity. It is suggested to be used as adjunct to current diabetic medications, as it exhibits antidiabetic properties.
Vuksan V., et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):46-56.
Liu Z, Wang LJ, Li X, Hu JN, Chen Y, Ruan CC, Sun GZ. Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice. Phytother Res. 2009 Oct;23(10):1426-30.
Yun SN, Ko SK, Lee KH, Chung SH. Vinegar-proceessed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice. Arch Pharm Res. 2007 May;30(5):587-95.
Xie JT, Mchendale S, Yuan CS. Ginseng and diabetes. Am J Chin Med. 2005;33(3):397-404.
Kiefer D, Pantuso T. Panax ginseng. Am Fam Physician. 2003 Oct 15;68(8):1539-42.
Chung SH, Choi CG, Park SH. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res. 2001 Jun;24(3):214-8.
Arushanian EB. Therapeutic potential of ginseng root preparations in treating diabetes mellitus. Eksp Klin Farmakol. 2009 Nov-Dec;72(6):52-6.
-
The Unique Blood Sugar Formula
- Vegan | non-GMO | Gluten Free
- Supports glucose metabolism*
- Supports pancreatic function*
- 100% natural herbal supplement
-
-
Suggested Use:
Take 3 tablets, three times a day with water before meals.
Important:
- If you have a medical condition, are allergic to any herbal ingredients or are taking prescription medication, consult your healthcare practitioner before using this product. Pregnant or nursing women should also consult your health care practitioner.
- Always monitor your blood glucose regularly (Recommended once every 2 days).
- At the beginning of taking Pancreton®, some may experience mild abdominal discomfort and/or minor diarrhea. These symptoms will gradually disappear; otherwise you may reduce the number of tablets taken each time.
Consult your physician prior to use if you are pregnant, nursing, taking medication, or have a medical condition. Do not use if you are allergic to any of the ingredients.
-
To view the general FAQ for Canfo Natural Products Click Here.
Q: What is Pancreton®?
A: Pancreton® is an herbal supplement designed to support glucose metabolism & pancreatic functions.
Q: How is Pancreton® different from other dietary supplements for glucose level?
A: Most dietary supplements on the market for a healthy glucose level are made with a single ingredient. Pancreton® uses a special formula to combine different ingredients of the highest quality in a unique way to help improve glucose metabolism & pancreatic function.
Q: Are there any things I need to do while taking Pancreton®?
A: In order to observe the progress of your glucose level, we strongly recommend that you monitor your blood sugar level frequently (at least once every two days) and record the results.
Q: Has Pancreton® been used by humans?
A: Pancreton® has been used by people since 2004 in Asia with positive results.
Q: How will Pancreton® affect my medication?
A: As with any supplement, people respond differently. Always consult your healthcare practitioner before using any supplement.
Q: Is it guaranteed to work for me?
A: Nobody can guarantee how your body is going to respond to Pancreton®. Based upon our experience many people live a happier life after they used Pancreton®. The best way to find out is by trying it yourself.
Q: Are all of the herbs in Pancreton® safe?
A: All of the ingredients of Pancreton® are safe with no known side-effects and have been used in other products on the market in the US. Always consult your healthcare practitioner if you have any questions about the ingredients.
Q: When I ask my doctor about Pancreton®, he felt herbs had no place in traditional medication. What should I do?
A: Your doctor's attitude towards herbs is common and we respect that. It is partly because there is no training on herbs or herbal medicines in Western medical schools and secondly there are few scientific studies done on the efficacy and safety of different herbs. However all the Pancreton® herbs have been scientifically researched and data has been published in various research journals.
Q: Are there any specific side effects of Pancreton®?
A: There are no known side effects of Pancreton®. However, about 10~20% of people who use Pancreton®, especially at the beginning, may experience mild abdominal discomfort and/or minor diarrhea. Typically these symptoms will gradually disappear. You may reduce the dosage of Pancreton® if you experience frequent diarrhea.
Q: Can a person on insulin take Pancreton®?
A: Always consult your healthcare practitioner if you are planning to take Pancreton® in addition to insulin.
Q: Is any special diet recommended with Pancreton®?
A: Just follow your healthcare practitioner's advice and do not consume alcohol as it can reverse the Pancreton® progress.